Xinhui Shi1, Qisong Li2, Yungang Wang1. 1. Department of Medical Laboratory, Yancheng No.1 People's Hospital & Yancheng First Hospital Affiliated Hospital of Nanjing University Medical School. 2. College of Medical Technology, Jiangsu Vocational College of Medicine, Yancheng, P.R. China.
Abstract
BACKGROUND: This meta-analysis aimed to systematically review current available literature to assess the impact of regulatory T cells (Tregs) on the prognosis of hepatocellular carcinoma (HCC). METHODS: We will browse the online databases of PubMed and Cochrane Library. The summary hazard ratio (HR) and their 95% confidence intervals (CIs) will be combined to present the value reported in the study. CONCLUSION: Our meta-analysis will provide useful guidance in treatment of HCC based on the reported evidences regarding the impact of Tregs on the prognosis of HCC. OSF REGISTRATION NUMBER: 10.17605/OSF.IO/3Q8PW.
BACKGROUND: This meta-analysis aimed to systematically review current available literature to assess the impact of regulatory T cells (Tregs) on the prognosis of hepatocellular carcinoma (HCC). METHODS: We will browse the online databases of PubMed and Cochrane Library. The summary hazard ratio (HR) and their 95% confidence intervals (CIs) will be combined to present the value reported in the study. CONCLUSION: Our meta-analysis will provide useful guidance in treatment of HCC based on the reported evidences regarding the impact of Tregs on the prognosis of HCC. OSF REGISTRATION NUMBER: 10.17605/OSF.IO/3Q8PW.
Authors: Christoph Bergmann; Clarissa A Wild; Mustafa Narwan; Ramin Lotfi; Stephan Lang; Sven Brandau Journal: Eur J Immunol Date: 2011-10-26 Impact factor: 5.532
Authors: Miral Sadaria Grandhi; Amy K Kim; Sean M Ronnekleiv-Kelly; Ihab R Kamel; Mounes A Ghasebeh; Timothy M Pawlik Journal: Surg Oncol Date: 2016-03-05 Impact factor: 3.279